Mycoplasma pneumoniae Genotypes and Clinical Outcome in Children-Reference-Cited by-同舟云学术

Mycoplasma pneumoniae Genotypes and Clinical Outcome in Children

Published:2021-06-18 Issue:7 Volume:59 Page:
ISSN:0095-1137
Container-title:Journal of Clinical Microbiology
language:en
Short-container-title:J Clin Microbiol

Author:

Meyer Sauteur Patrick M.¹^ORCID,Pánisová Elena¹^ORCID,Seiler Michelle²^ORCID,Theiler Martin³^ORCID,Berger Christoph¹^ORCID,Dumke Roger⁴^ORCID

Affiliation:

1. Division of Infectious Diseases and Hospital Epidemiology, University Children’s Hospital Zurich, Zurich, Switzerland

2. Emergency Department, University Children’s Hospital Zurich, Zurich, Switzerland

3. Pediatric Skin Center, Department of Dermatology, University Children’s Hospital Zurich, Zurich, Switzerland

4. TU Dresden, Medical Faculty Carl Gustav Carus, Institute of Medical Microbiology and Hygiene, Dresden, Germany

Abstract

Factors leading to the wide range of manifestations associated with Mycoplasma pneumoniae infection are unclear. We investigated whether M. pneumoniae genotypes are associated with specific clinical outcomes.

Funder

Walter and Gertrud Siegenthaler Fellowship

Filling the Gap of the University of Zurich

Publisher

American Society for Microbiology

Subject

Microbiology (medical)

Link

https://journals.asm.org/doi/pdf/10.1128/JCM.00748-21

Reference52 articles.

1. Community-Acquired Pneumonia Requiring Hospitalization among U.S. Children

2. Mycoplasma pneumoniaeand Its Role as a Human Pathogen

3. Fatal Outcomes in Family Transmission of Mycoplasma pneumoniae

4. Acute respiratory distress syndrome during the COVID-19 pandemic: not only SARS-CoV-2

5. Pathogenesis of extrapulmonary manifestations of Mycoplasma pneumoniae infection with special reference to pneumonia

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CHAMP: A Centrifugal Microfluidics-Based CRISPR/Cas12b-Combined Real-Time LAMP One-Pot Method for Mycoplasma pneumoniae Infection Diagnosis;ACS Omega;2024-09-06

2. Increased macrolide resistance rate of Mycoplasma pneumoniae correlated with epidemic in Beijing, China in 2023;Frontiers in Microbiology;2024-08-06

3. Macrolide-resistant mycoplasma pneumoniae infection in children observed during a period of high incidence in Henan, China;Heliyon;2024-07

4. miRNA, lncRNA and circRNA: targeted molecules with therapeutic promises in Mycoplasma pneumoniae infection;Archives of Microbiology;2023-07-21

5. Molecular epidemiology of Mycoplasma pneumoniae pneumonia in children, Wuhan, 2020-2022;2023-05-09